ALERT: ISSUE IDENTIFIED IN BPL PLASMA PRODUCTS PRODUCTION
ISSUE IDENTIFIED IN BPL PLASMA PRODUCTS PRODUCTION 19TH JULY 2017 JEFFERSON COURTNEY The Department of Health (DH) published a statement (below) this morning regarding an issue identified during a routine inspection of Bio Products Laboratory (BPL) and their production of plasma derived blood products. The statement says that there was a problem with the computer software which controls the […]
Read more